In 2025, the market in BRICS stood at USD 74.49 billion, showing a year-over-year growth rate of 12.0%.
By 2033, the BRICS Infusion Services Market will attain USD 243.73 billion, with a projected CAGR of 16.0% across the forecast window.
Emerging economy healthcare investment is strengthening specialty hospital infrastructure, driving expansion of infusion-based oncology and autoimmune treatment programs.
BRICS health ministers’ joint declarations highlight coordinated focus on cancer control and biologic access, reinforcing systemic therapy growth momentum.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]